Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 141741 | Other Identifier | Health Canada: Therapeutic Products Directorate |
Not provided
Not provided
Not provided
Lack of definitive clinical results.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test if olopatadine punctal plugs can reduce the symptoms (itching) of allergic conjunctivitis to ragweed in an Environmental Exposure Chamber model.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lower Puncta Delivery | Experimental |
| |
| Double Puncta Delivery | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Olopatadine | Drug | low dose |
| |
| Olopatadine |
| Measure | Description | Time Frame |
|---|---|---|
| Safety of olopatadine-PPDS in subjects with seasonal allergic conjunctivitis to ragweed | 4 Days | |
| Change from baseline in subject-rated ocular itching scores in treated vs placebo control arms in subjects with seasonal allergic conjunctivitis to ragweed | 4 days |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline and observed values in subject rated ocular itching scores compared between lower puncta delivery and double puncta delivery arms | 4 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dipak Panigrahi, MD | QLT Inc. | Study Director |
| Deepen Patel, MD | Cetero Research, San Antonio | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cetero Research | Toronto | Ontario | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
high dose |
|
| ID | Term |
|---|---|
| D000069605 | Olopatadine Hydrochloride |
| ID | Term |
|---|---|
| D003990 | Dibenzoxepins |
| D006575 | Heterocyclic Compounds, 3-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided